
Gelesis Investor Relations Material
Latest events

Q4 2022
Gelesis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Gelesis Holdings Inc
Access all reports
Gelesis Holdings Inc. is a biotechnology company focused on developing products for weight management and metabolic health. The company creates therapeutics designed to treat obesity and other related conditions using hydrogel technology. Gelesis’ products are intended to aid in weight loss by creating a sensation of fullness, and they are based on its proprietary biomaterials platform. The company’s offerings target individuals seeking weight management solutions and those at risk of obesity-related health issues. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NYSE.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
GLS
Country
🇺🇸 United States